Anxiety, depression, physical disease parameters and health-related quality of life in the BronchUK national bronchiectasis cohort

©The authors 2025. Background: Bronchiectasis is associated with psychological comorbidity and poor quality of life (QoL), yet guidelines lack focus on psychological morbidity. Using data obtained from the BronchUK database (1341 patients), we examined the link between anxiety/depression and physical disease severity, QoL and long-term outcomes in bronchiectasis. Methods: Computed tomography-confirmed bronchiectasis patients enrolled in the BronchUK study with Hospital Anxiety and Depression Scale (HADS-A/D) data were studied. HADS-A/D scores ⩾8 indicated anxiety/depression. QoL was measured by the St George’s Respiratory Questionnaire and QoL-Bronchiectasis Questionnaire. Exacerbations during annual follow-up were analysed by negative binomial regression with time in study as an offset adjusted for age, body mass index, sex, Pseudomonas infection, diabetes and forced expiratory volume in 1 s (FEV1). Cox regression determined probability of hospitalisation using time to first exacerbation. Results 1341 patients were included; 418 had anxiety (31%), 269 (20%) had depression and 201 (15%) had both conditions. HADS-A/D ⩾8 was associated with worse QoL (p<0.0001) and clinical severity (e.g. Bronchiectasis Severity Index, FEV1 and Medical Research Council dyspnoea score (all p<0.01). HADS-A/D ⩾8 each was associated with exacerbation (rate ratio (RR) 1.42, 95% CI 1.32–1.52 for HADS-A; RR 1.45, 95% CI 1.34–1.56 for HADS-D, both p<0.0001) and hospitalisation risk (RR 1.58, 95% CI 1.29– 1.92 for HADS-A; RR 1.76, 95% CI 1.43–2.17 for HADS-D, both p<0.001). HADS-A/D ⩾8 each predicted future hospitalisation (HR 1.30, 95% CI 0.98–1.72, p=0.067 for HADS-A; HR 1.40 95% CI 1.04–1.88, p=0.027 for HADS-D). Interpretation Anxiety and depression are common in bronchiectasis, correlate with disease severity and predict poor outcomes. Consideration of psychological comorbidities should be evaluated in routine bronchiectasis care.

Publication Details

Journal
Newcastle University ePrints (Newcastle Univesity)
Published
2025-06-16
DOI
https://doi.org/10.57711/gg71-6m68
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anxiety, depression, physical disease parameters and health-related quality of life in the BronchUK national bronchiectasis cohort

Newcastle University ePrints (Newcastle Univesity)
Cystic Fibrosis Research Advances
article

Anxiety, depression, physical disease parameters and health-related quality of life in the BronchUK national bronchiectasis cohort

article en

Abstract

©The authors 2025. Background: Bronchiectasis is associated with psychological comorbidity and poor quality of life (QoL), yet guidelines lack focus on psychological morbidity. Using data obtained from the BronchUK database (1341 patients), we examined the link between anxiety/depression and physical disease severity, QoL and long-term outcomes in bronchiectasis. Methods: Computed tomography-confirmed bronchiectasis patients enrolled in the BronchUK study with Hospital Anxiety and Depression Scale (HADS-A/D) data were studied. HADS-A/D scores ⩾8 indicated anxiety/depression. QoL was measured by the St George’s Respiratory Questionnaire and QoL-Bronchiectasis Questionnaire. Exacerbations during annual follow-up were analysed by negative binomial regression with time in study as an offset adjusted for age, body mass index, sex, Pseudomonas infection, diabetes and forced expiratory volume in 1 s (FEV1). Cox regression determined probability of hospitalisation using time to first exacerbation. Results 1341 patients were included; 418 had anxiety (31%), 269 (20%) had depression and 201 (15%) had both conditions. HADS-A/D ⩾8 was associated with worse QoL (p<0.0001) and clinical severity (e.g. Bronchiectasis Severity Index, FEV1 and Medical Research Council dyspnoea score (all p<0.01). HADS-A/D ⩾8 each was associated with exacerbation (rate ratio (RR) 1.42, 95% CI 1.32–1.52 for HADS-A; RR 1.45, 95% CI 1.34–1.56 for HADS-D, both p<0.0001) and hospitalisation risk (RR 1.58, 95% CI 1.29– 1.92 for HADS-A; RR 1.76, 95% CI 1.43–2.17 for HADS-D, both p<0.001). HADS-A/D ⩾8 each predicted future hospitalisation (HR 1.30, 95% CI 0.98–1.72, p=0.067 for HADS-A; HR 1.40 95% CI 1.04–1.88, p=0.027 for HADS-D). Interpretation Anxiety and depression are common in bronchiectasis, correlate with disease severity and predict poor outcomes. Consideration of psychological comorbidities should be evaluated in routine bronchiectasis care.

Newcastle University ePrints (Newcastle Univesity)
No poverty
Openalex Percentile: Top 36%
Cystic Fibrosis Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Anxiety, depression, physical disease parameters and health-related quality of life in the BronchUK national bronchiectasis cohort · Newcastle University ePrints (Newcastle Univesity) (2025) | TGRS Research Map | TGRS